Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand–receptor interactions: theory and application to HIV treatment

Tew, 1990, Follicular dendritic cells as accessory cells, Immunol. Rev., 117, 185, 10.1111/j.1600-065X.1990.tb00573.x Mandel, 1980, The follicular dendritic cell: long term antigen retention during immunity, Immunol. Rev., 53, 29, 10.1111/j.1600-065X.1980.tb01039.x Pantaleo, 1994, Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection, Immunol. Rev., 140, 105, 10.1111/j.1600-065X.1994.tb00867.x Haase, 1999, Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues, Annu. Rev. Immunol., 17, 625, 10.1146/annurev.immunol.17.1.625 Haase, 1996, Quantitative image analysis of HIV-1 infection in lymphoid tissue, Science, 274, 985, 10.1126/science.274.5289.985 Kuster, 2000, Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection, Am. J. Pathol., 156, 1973, 10.1016/S0002-9440(10)65070-5 Heath, 1995, Follicular dendritic cells and human immunodeficiency virus infectivity, Nature, 377, 740, 10.1038/377740a0 Joling, 1993, Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent, J. Immunol., 150, 1065, 10.4049/jimmunol.150.3.1065 Schmitz, 1994, Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia, J. Immunol., 153, 1352, 10.4049/jimmunol.153.3.1352 Hlavacek, 2000, Influence of follicular dendritic cells on HIV dynamics, Philos. Trans. R. Soc. Lond. B, 355, 1051, 10.1098/rstb.2000.0642 Hlavacek, 2000, Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy, Proc. Nat. Acad. Sci. USA, 97, 10966, 10.1073/pnas.190065897 Müller, 2001, Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood, J. Virol., 75, 2597, 10.1128/JVI.75.6.2597-2603.2001 Cavert, 1997, Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection, Science, 276, 960, 10.1126/science.276.5314.960 Wong, 1997, Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure, Proc. Nat. Acad. Sci. USA, 94, 12574, 10.1073/pnas.94.23.12574 Tenner-Racz, 1998, The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy, J. Exp. Med., 187, 949, 10.1084/jem.187.6.949 Orenstein, 1999, Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen. Restoration after involution and CD4 cell depletion in an AIDS patient, AIDS, 13, 2219, 10.1097/00002030-199911120-00004 Opravil, 2000, Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy, JAIDS, 23, 17, 10.1097/00126334-200001010-00003 Fischer, 2000, Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy, AIDS Res. Hum. Retroviruses, 16, 1135, 10.1089/088922200414974 Zhang, 1999, Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy, N. Engl. J. Med., 340, 1605, 10.1056/NEJM199905273402101 Natarajan, 1999, HIV-1 replication in patients with undetectable plasma virus receiving HAART, Lancet, 353, 119, 10.1016/S0140-6736(05)76156-0 Lewin, 1999, Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy, J. Virol., 73, 6099, 10.1128/JVI.73.7.6099-6103.1999 Furtado, 1999, Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy, N. Engl. J. Med., 340, 1614, 10.1056/NEJM199905273402102 Dornadula, 1999, Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy, JAMA, 282, 1627, 10.1001/jama.282.17.1627 Sharkey, 2000, Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy, Nat. Med., 6, 76, 10.1038/71569 Burton, 1997, Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives, Immunol. Rev., 156, 185, 10.1111/j.1600-065X.1997.tb00968.x Smith, 2001, Persistence of infectious HIV on follicular dendritic cells, J. Immunol., 166, 690, 10.4049/jimmunol.166.1.690 Chun, 2000, Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy, Nat. Med., 6, 757, 10.1038/77481 Imamichi, 2001, Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy, J. Infect. Dis., 183, 36, 10.1086/317641 Chun, 1999, Latent reservoirs of HIV: obstacles to the eradication of virus, Proc. Nat. Acad. Sci. USA, 96, 10958, 10.1073/pnas.96.20.10958 Perelson, 1997, Decay characteristics of HIV-1-infected compartments during combination therapy, Nature, 387, 188, 10.1038/387188a0 Autran, 1997, Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease, Science, 277, 112, 10.1126/science.277.5322.112 Zhang, 1998, Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection, Proc. Nat. Acad. Sci. USA, 95, 1154, 10.1073/pnas.95.3.1154 Zhang, 1999, Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection, Proc. Nat. Acad. Sci. USA, 96, 5169, 10.1073/pnas.96.9.5169 Schacker, 2000, Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy, J. Infect. Dis., 181, 354, 10.1086/315178 Knuchel, 2000, Impact of TNFα, LTα, FcγRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients, AIDS, 14, 2661, 10.1097/00002030-200012010-00005 Hlavacek, 1999, Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis, Proc. Nat. Acad. Sci. USA, 96, 14681, 10.1073/pnas.96.26.14681 Stoiber, 1997, Role of complement in HIV infection, Annu. Rev. Immunol., 15, 649, 10.1146/annurev.immunol.15.1.649 Kacani, 2000, Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2, J. Virol., 74, 7997, 10.1128/JVI.74.17.7997-8002.2000 Heinen, 1985, Isolation of follicular dendritic cells from human tonsils and adenoids. III. Analysis of their Fc receptors, Immunology, 54, 777 Fujiwara, 1999, Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interaction, J. Virol., 73, 3603, 10.1128/JVI.73.5.3603-3607.1999 Ross, 1985, Membrane complement receptors specific for bound fragments of C3, Adv. Immunol., 37, 217, 10.1016/S0065-2776(08)60341-7 Gentile, 1994, Determination of the size of HIV using adenovirus type 2 as an internal length marker, J. Virol. Meth., 48, 43, 10.1016/0166-0934(94)90087-6 Turner, 1999, Structural biology of HIV, J. Molec. Biol., 285, 1, 10.1006/jmbi.1998.2354 Forster, 2000, Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography, J. Molec. Biol., 298, 841, 10.1006/jmbi.2000.3715 Jakubik, 1999, B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1, Immunology, 96, 612, 10.1046/j.1365-2567.1999.00304.x Jakubik, 2000, Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes, J. Virol., 74, 552, 10.1128/JVI.74.1.552-555.2000 Doepper, 2000, B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement, Immunobiology, 202, 293, 10.1016/S0171-2985(00)80035-2 Moir, 2000, B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells, J. Exp. Med., 192, 637, 10.1084/jem.192.5.637 Perelson, 1981, Receptor clustering on a cell surface. III. Theory of receptor cross-linking by multivalent ligands: description by ligand states, Math. Biosci., 53, 1, 10.1016/0025-5564(81)90036-5 Frémeaux-Bacchi, 1996, Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23, Eur. J. Immunol., 26, 1497, 10.1002/eji.1830260714 Rasmussen, 1988, Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell lines, Complement, 5, 98, 10.1159/000463040 Tooze, 1991, Decreased expression of complement receptory type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia, Clin. Exp. Immunol., 83, 423, 10.1111/j.1365-2249.1991.tb05655.x Reynes, 1985, Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens, J. Immunol., 135, 2687, 10.4049/jimmunol.135.4.2687 Szakal, 1985, Isolated follicular dendritic cells: cytochemical antigen localization, Nomarski, SEM, and TEM morphology, J. Immunol., 134, 1349, 10.4049/jimmunol.134.3.1349 Taylor, 1984 Goldstein, 1989, Competition between solution and cell surface receptors for ligand: dissociation of hapten bound to surface antibody in the presence of solution antibody, Biophys. J., 56, 955, 10.1016/S0006-3495(89)82741-9 Goldstein, 1989, Diffusion limited effects of receptor clustering, Comm. Theor. Biol., 1, 109 Goldstein, 1996, Why is it so hard to dissociate multivalent antigens from cell-surface antibodies?, Immunol. Today, 17, 77, 10.1016/0167-5699(96)80583-4 Xu, 1998, Kinetics of multivalent antigen DNP-BSA binding to IgE-FcϵRI in relationship to the stimulated tyrosine phophorylation of FcϵRI, J. Immunol., 160, 3225, 10.4049/jimmunol.160.7.3225 Hlavacek, 1999, Quantifying aggregation of IgE-FcϵRI by multivalent antigen, Biophys. J., 76, 2421, 10.1016/S0006-3495(99)77397-2